Brain Cancer

8 protocols meet the specified criteria.

• A151804

  Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events

• A211901

  Reaching Rural Cancer Survivors Who Smoke Using Test-Based Cessation Interventions

• COG-ANBL2131

  A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children with Newly Diagnosed High-Risk Neuroblastoma

• EAF223

  GABLE: Phase II Glioblastoma Accelerated Biomarkers Learning Environment Trial

• EAY191

  Molecular Analysis for Combination Therapy Choice (ComboMATCH)

• F8394-201

  A Phase 2 Master Protocol to assess the efficacy and safety of FORE8394, an inhibitor of BRAF class 1 and class 2 alterations, in participants with cancer harboring BRAF alterations

• GRAIL-MA-002

  REACH Study: Real-world Evidence to Advance Multi-Cancer Early Detection Health Equity (REACH/Galleri-Medicare study)

• WVU011625

  The role of scheduled intravenous fluids in the supportive management of patients undergoing chemo-radiotherapy for head and neck cancers